Sign In
Last checked at 
20 Dec 2021 08:45
ConvaTec Group Plc
Block Listing Application
Reading, United Kingdom - 20 December 2021
An application has been made to the Financial Conduct Authority and the London Stock Exchange for a block listing totalling 20,000,000 ordinary shares of 10 pence each ("Shares") to be admitted to the premium listing segment of the Official List of the FCA and to trading on the London Stock Exchange's main market for listed securities. When issued these Shares will rank pari passu with the existing ordinary shares.
These Shares are being reserved under a block listing and will be issued from time to time pursuant to the following scheme(s):
Scheme | Number of Shares |
ConvaTec Group Plc Long Term Incentive Plan | 9,850,000 |
ConvaTec Group Plc US Employee Stock Purchase Plan | 290,000 |
ConvaTec Group Plc Share Plan | 3,000,000 |
ConvaTec Group Plc Deferred Bonus Plan | 430,000 |
ConvaTec Group Plc UK SAYE | 1,830,000 |
ConvaTec Group Plc Global SAYE Sub-Plan | 4,600,000 |
Admission of the Shares is expected on 21 December 2021.
Enquiries
Analysts and Investors
Kate Postans, VP Investor Relations, ConvaTec +44 (0)782 644 7807
ir@convatec.com
Media
Buchanan: Chris Lane +44 (0)207 466 5000
ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92
About ConvaTec
ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion care. Our vision, which encompasses our purpose, is: Pioneering trusted medical solutions to improve the lives we touch. Our products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. To learn more about ConvaTec, please visit www.convatecgroup.com
Follow the stocks
